ConferenceIn person

EACR Overcoming Therapy Resistance: Outsmarting intratumour heterogeneity and plasticity

Name: EACR Overcoming Therapy Resistance: Outsmarting intratumour heterogeneity and plasticity
Start: 2027-04-20
End: 2027-04-22
Location: École Normale Supérieure de Lyon (Site Monod)

Hosted by European Association for Cancer Research (EACR)

20 – 22 April 2027
Add to calendar
Apple / Outlook (.ics)Google Calendar
Welcome to kongre.net
Events Categories News
École Normale Supérieure de Lyon (Site Monod), Lyon, France
Clinical MedicineOncology & Cancer Research

Let others know you'll be there. This does not register you for the event.

Welcome to kongre.net

Official website

Programme

Published

30 sessions across 3 days

16 speakers

Browse programme

Call for Papers

Submissions are handled by the organiser

View submission details

Registration

Registration is handled by the organiser

Go to registration

Key facts

EACR Overcoming Therapy Resistance: Outsmarting intratumour heterogeneity and plasticity is a conference held 20 – 22 April 2027 in École Normale Supérieure de Lyon (Site Monod), Lyon, France, organised by European Association for Cancer Research (EACR).

Dates:: 20 – 22 April 2027
Format:: In person
Venue:: École Normale Supérieure de Lyon (Site Monod), Lyon, France
Subjects:: Oncology & Cancer Research
Organiser:: European Association for Cancer Research (EACR)
Official website:: eacr.org/conference/overcoming-therapy-resistance-2027

This conference tackles why tumours adapt and resist therapy, focusing on intratumour heterogeneity, cellular plasticity, and the tumour immune microenvironment.

Conference theme

Outsmarting intratumour heterogeneity and plasticity

Objectives

To bring together international leaders to explore how tumour complexity evolves, examine driver cell states, dissect and rewire the tumour microenvironment, and counter therapy resistance.

Who should attend

Researchers, clinicians, and allied health professionals focused on cancer biology, translational cancer research, medical oncology, and immunotherapy.

Organising Committee

Chris Marine - Chair, VIB-KU Leuven Center for Human Genetics, Belgium Toni Celia-Terrassa - Hospital del Mar Research Institute, Spain Marta Kovatcheva - IFOM, Italy Caroline Robert - The Institute - Gustave Roussy, France